Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C

Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C

Item
http://www.wikidata.org/entity/Q37304715
Lipid-lowering efficacy of rosuvastatinPleiotropic effects of statins in the diseases of the liverLipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesStatin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents.Cholesterol and chronic hepatitis C virus infection.Are there any benefits from statin treatment for the septic patient?Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityHepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis.Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.Host-targeting therapies for hepatitis C virus infection: current developments and future applications.
P2860

Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C

Item
http://www.wikidata.org/entity/Q37304715
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Open-label, ascending dose, pr ...... ients with chronic hepatitis C
@en
Open-label, ascending dose, pr ...... ents with chronic hepatitis C.
@nl
type
label
Open-label, ascending dose, pr ...... ients with chronic hepatitis C
@en
Open-label, ascending dose, pr ...... ents with chronic hepatitis C.
@nl
prefLabel
Open-label, ascending dose, pr ...... ients with chronic hepatitis C
@en
Open-label, ascending dose, pr ...... ents with chronic hepatitis C.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Open-label, ascending dose, pr ...... ients with chronic hepatitis C
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2893.2010.01310.X
P433
P478
P577
P698
P932